<DOC>
	<DOCNO>NCT02398903</DOCNO>
	<brief_summary>The aim study assess concentration different oral contraceptive agent morbid obese woman two type bariatric surgery ( RYGB sleeve gastrectomy ) order study role surgery role body weight drug concentration , compare concentration normal-weight woman .</brief_summary>
	<brief_title>Evaluation Hormonal Contraceptive Treatments Obese Women</brief_title>
	<detailed_description>Open , multi-center pharmacological study residual concentration three different oral contraceptive 3 group obese woman group surgery , 1 group healthy volunteer . The concentration assess , 6 12 month bariatric surgery restrictive ( sleeve gastrectomy ) malabsorptive ( gastric pas ) . Contraception important issue woman obesity . There actually data answer question efficacy oral contraceptive obese woman , condition could risk factor failure hormonal contraception , due change drug metabolism large volume distribution obesity . Bariatric surgery efficient therapeutic weight loss severe morbid obesity . In 2011 , 31 000 bariatric procedure perform France sleeve gastrectomy Roux-en-Y gastric bypass ( RYGB ) represent two frequent procedure . Women represent 80 % surgical patient childbearing age ( mean age 39 year ) . Obese woman receive surgical treatment obesity advise conceive follow 12 18 month , ensure optimal weight loss stable weight pregnancy , also begin pregnancy optimal nutritional vitamin status . There data change oral contraceptive concentration bariatric surgery , malabsorption anatomic digestive modification follow surgery may theoretically affect bioavailability . Primary Objective : The difference Css bariatric surgery 6 month surgery obese woman regardless oral contraceptive use . Three different oral contraceptive employ ( two combine oral contraceptive contain ethinyl E2 levonorgestrel progestin contraceptive desogestrel ) . Secondary Objectives : - To assess difference Css , 6 month 12 month surgery 3 group oral contraceptive 2 group surgery - To compare Css obese woman , 6 month 12 month surgery T0 Css normal-weight patient group oral contraceptive - To assess impact oral contraceptive gonadotroph axis , hemostatic variable estrogen-sensitive protein obese woman 6 12 month surgery normal-weight woman - Analyze correlation body composition , nutritional status Css 3 group oral contraceptive 2 group bariatric surgery Secondary End Points : - Css oral contraceptive agent 12 month bariatric surgery - Css oral contraceptive agent normal weight woman - Sequential Body composition DXA Impedancemetry 6 month 12 month surgery . - Nutritional status obese woman surgery ( albumin , prealbuminemia , RBP , transferrin , haemoglobin , lipid ( total cholesterol , triglyceride , LDL HDL ) - Evaluation gonadotroph axis hormonal assay : FSH , LH , estradiol , AMH , progesterone , testosterone total , Inhibin B normal-weight woman obese woman 6 month 12 month surgery - Evaluation hemostatic variable ( protein S , APC ) SHBG normal-weight woman obese woman 6 month 12 month surgery - Number unexpected pregnancy occur study</detailed_description>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Eligibility Criteria : Inclusion criterion : Obese woman Obese woman ( BMI ≥ 35 kg/m² obesity relate comorbidity BMI ≥ 40 kg/m² ) indication bariatric surgery RYGB sleeve gastrectomy oral contraceptive treatment interest study Aged 18 45 year desogestrel 18 35 year COC Signed informed consent Affiliated The French Social Security Health insurance Healthy Volunteers Normal weight ( BMI &lt; 25 kg/m² ) Women oral contraceptive treatment Aged 18 45 year Signed informed consent Affiliated The French Social Security Health insurance Exclusion criterion : Drug treatment know interact cytochrome P450 ( CYP3A4 ) . Contraindication oral contraceptive agent mention summary product characteristic Positive pregnancy test</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Morbid obesity</keyword>
	<keyword>bariatric surgery</keyword>
	<keyword>sleeve gastrectomy</keyword>
	<keyword>Roux-en-Y gastric bypass</keyword>
	<keyword>hormonal contraception</keyword>
	<keyword>combine oral contraceptive</keyword>
	<keyword>progestin contraceptive desogestrel</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>